Literature DB >> 17278130

Differential distribution of the MeCP2 splice variants in the postnatal mouse brain.

Joanna M Dragich1, Yong-Hwan Kim, Arthur P Arnold, N Carolyn Schanen.   

Abstract

Mutations in the gene encoding methyl CpG binding protein 2 (MeCP2) are the primary cause of the neurodevelopmental disorder Rett syndrome (RTT). Mecp2-deficient mice develop a neurological phenotype that recapitulates many of the symptoms of RTT, including postnatal onset of the neurological deficits. MeCP2 has two isoforms, MeCP2e1 and MeCP2e2, with distinct amino termini, which are generated by alternative splicing. We examined the distribution of the Mecp2 splice variants in the postnatal mouse brain by in situ hybridization and found regional and age-related differences in transcript abundance. In newborn mice, signals for total Mecp2 and the Mecp2e2 transcripts were widely distributed, with overlapping expression patterns throughout the brain. Expression of the Mecp2e2 splice variant became largely restricted to nuclei within the dorsal thalamus (DT) and cortical layer V in juvenile animals, a pattern that was maintained into adulthood. In contrast, the total Mecp2 riboprobe only weakly labeled the DT and cortical layer V in juvenile and adult animals, although it heavily labeled surrounding brain regions, suggesting that Mecp2e1 is the predominant transcript outside the thalamus. Quantitative real-time PCR was used to measure Mecp2e1 and Mecp2e2 abundance in the diencephalon of adult mice, demonstrating significantly more Mecp2e2 in the DT than in the hypothalamus, which is in agreement with the Mecp2e2 in situ hybridization. The differential distribution of the Mecp2e1 and Mecp2e2 transcripts indicates regional and developmental regulation of Mecp2 splicing in the postnatal mouse brain. (c) 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17278130     DOI: 10.1002/cne.21264

Source DB:  PubMed          Journal:  J Comp Neurol        ISSN: 0021-9967            Impact factor:   3.215


  47 in total

Review 1.  Complexities of Rett syndrome and MeCP2.

Authors:  Rodney C Samaco; Jeffrey L Neul
Journal:  J Neurosci       Date:  2011-06-01       Impact factor: 6.167

Review 2.  Epigenetics, autism spectrum, and neurodevelopmental disorders.

Authors:  Sampathkumar Rangasamy; Santosh R D'Mello; Vinodh Narayanan
Journal:  Neurotherapeutics       Date:  2013-10       Impact factor: 7.620

Review 3.  Experimental models of Rett syndrome based on Mecp2 dysfunction.

Authors:  Gaston Calfa; Alan K Percy; Lucas Pozzo-Miller
Journal:  Exp Biol Med (Maywood)       Date:  2011-01

Review 4.  Epigenetic mechanisms in diurnal cycles of metabolism and neurodevelopment.

Authors:  Weston T Powell; Janine M LaSalle
Journal:  Hum Mol Genet       Date:  2015-06-23       Impact factor: 6.150

5.  MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites.

Authors:  Rajarshi P Ghosh; Rachel A Horowitz-Scherer; Tatiana Nikitina; Luda S Shlyakhtenko; Christopher L Woodcock
Journal:  Mol Cell Biol       Date:  2010-08-02       Impact factor: 4.272

6.  Methyl CpG-binding protein isoform MeCP2_e2 is dispensable for Rett syndrome phenotypes but essential for embryo viability and placenta development.

Authors:  Masayuki Itoh; Candice G T Tahimic; Shuhei Ide; Akihiro Otsuki; Toshikuni Sasaoka; Shigeru Noguchi; Mitsuo Oshimura; Yu-ichi Goto; Akihiro Kurimasa
Journal:  J Biol Chem       Date:  2012-02-28       Impact factor: 5.157

Review 7.  Rett syndrome and MeCP2.

Authors:  Vichithra R B Liyanage; Mojgan Rastegar
Journal:  Neuromolecular Med       Date:  2014-03-11       Impact factor: 3.843

Review 8.  Recent advances in MeCP2 structure and function.

Authors:  Kristopher C Hite; Valerie H Adams; Jeffrey C Hansen
Journal:  Biochem Cell Biol       Date:  2009-02       Impact factor: 3.626

9.  Structural and functional differences in the barrel cortex of Mecp2 null mice.

Authors:  Li-Jen Lee; Vassiliy Tsytsarev; Reha S Erzurumlu
Journal:  J Comp Neurol       Date:  2017-09-15       Impact factor: 3.215

10.  MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy.

Authors:  Mojgan Rastegar; Akitsu Hotta; Peter Pasceri; Maisam Makarem; Aaron Y L Cheung; Shauna Elliott; Katya J Park; Megumi Adachi; Frederick S Jones; Ian D Clarke; Peter Dirks; James Ellis
Journal:  PLoS One       Date:  2009-08-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.